Lv51
1130 积分 2024-11-23 加入
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial
8天前
已完结
Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China
8天前
已完结
Tedizolid for osteoarticular infections: evaluation of the published evidence
8天前
已关闭
Advancing global antifungal development to combat invasive fungal infection
9天前
已完结
A safer polyene antifungal
9天前
已完结
Design of a renal-sparing antifungal
9天前
已完结
Analysis of the risk factors of linezolid‐related haematological toxicity in Chinese patients
17天前
已完结
Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations
17天前
已完结
Lecanemab in Early Alzheimer’s Disease
1个月前
已完结
Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations
2个月前
已关闭
皖公网安备34019202002308
